FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to a method for preparing a pharmaceutical composition comprising an anti-TNFα antibody, a method for using hexanedioic acid to modulate the immunogenicity of a pharmaceutical composition, as well as a pharmaceutical composition and a method for modulating immune responses. Composition comprises an anti-TNFα antibody buffer comprising hexanedioic acid or at least one salt thereof and/or citric acid or at least one salt thereof.
EFFECT: modulation of immune responses related to the administration of a biopharmaceutical drug.
18 cl, 4 tbl, 2 ex, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING BIOPHARMACEUTICAL DRUG | 2011 |
|
RU2587056C2 |
LIQUID COMPOSITION OF AN ANTIBODY AGAINST TNF ALPHA | 2018 |
|
RU2756619C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ADALIMUMAB | 2014 |
|
RU2664736C2 |
COMPOSITION FOR TREATING DISEASE | 2009 |
|
RU2531548C2 |
ANTIBODIES AGAINST TNF-α AND USE THEREOF | 2010 |
|
RU2595379C2 |
STABLE COMPOSITIONS WITH HIGH CONCENTRATIONS OF PROTEINS OF HUMAN ANTIBODIES AGAINST TNF-ALPHA | 2010 |
|
RU2560701C2 |
TRISPECIFIC IL-17A, IL-17F AND OTHER PROINFLAMMATORY MOLECULES ANTIBODIES | 2016 |
|
RU2680011C2 |
AUTOMATIC INJECTION DEVICE | 2007 |
|
RU2438721C2 |
METHODS FOR IDENTIFYING ANTIBODIES WITH REDUCED IMMUNOGENICITY | 2013 |
|
RU2648141C2 |
SET FOR DETECTING SPORES, ORIGINATING FROM MYCOBACTERIA | 2008 |
|
RU2559782C2 |
Authors
Dates
2018-07-26—Published
2014-07-21—Filed